Floatz logo

CYTARABINE

Acute Myeloid Leukemia With 11q23 Abnormalities

Alice MimsSmall moleculePhase 3Active
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
67/ 100
Competitive Position
95/ 100

Competitive context

24 Active assets in the Acute Myeloid Leukemia With 11q23 Abnormalities cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
M.D. Anderson Cancer Center
Phase 3BBB
Daunorubicin
National Cancer Institute (NCI)
Phase 3BBB
Idarubicin
Bruno C. Medeiros
Phase 2BBB
Cyclophosphamide
M.D. Anderson Cancer Center
Phase 3BBB
Fludarabine
M.D. Anderson Cancer Center
Phase 3BBB

View all 50 →

Same molecule, other indications

CYTARABINE is also rated in:

acute promyelocytic leukemiaActive
A
Indicative · Phase 4
82 / 100
View asset →
adult acute lymphoblastic leukemiaActive
BBB
Indicative · Phase 4
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative · Phase 3
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →